Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) EPS (Basic): 2018-2025

Historic EPS (Basic) for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -$0.85.

  • Bicycle Therapeutics' EPS (Basic) fell 14.86% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.62, marking a year-over-year decrease of 11.04%. This contributed to the annual value of -$2.90 for FY2024, which is 42.91% up from last year.
  • Per Bicycle Therapeutics' latest filing, its EPS (Basic) stood at -$0.85 for Q3 2025, which was up 25.44% from -$1.14 recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' EPS (Basic) ranged from a high of -$0.59 in Q3 2021 and a low of -$1.41 during Q2 2023.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.88 (2025), whereas its average is -$0.99.
  • Per our database at Business Quant, Bicycle Therapeutics' EPS (Basic) tumbled by 65.57% in 2022 and then surged by 52.31% in 2024.
  • Bicycle Therapeutics' EPS (Basic) (Quarterly) stood at -$0.61 in 2021, then slumped by 65.57% to -$1.01 in 2022, then declined by 11.88% to -$1.13 in 2023, then spiked by 33.63% to -$0.75 in 2024, then fell by 14.86% to -$0.85 in 2025.
  • Its EPS (Basic) was -$0.85 in Q3 2025, compared to -$1.14 in Q2 2025 and -$0.88 in Q1 2025.